News Daily News Experience Matters as Ross Procedure Gains Popularity in North America Michael O'Riordan March 06, 2026
News Daily News Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial Michael O'Riordan February 19, 2026
News Daily News Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass Yael L. Maxwell January 14, 2026
News Daily News Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI Yael L. Maxwell December 29, 2025
News Conference News AHA 2025 CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI Michael O'Riordan November 11, 2025
News Conference News AHA 2025 Liberal Transfusion Doesn’t Decrease MACE in Surgery Patients at High Cardiac Risk: TOP Caitlin E. Cox November 10, 2025
News Conference News EACTS 2025 Mortality at 4 Years After TAVI Explant Linked to Hospital Volume: Medicare Data Yael L. Maxwell October 16, 2025
News Conference News EACTS 2025 Nearly Half of CABG Patients Have New-Onset AF, but It Often Doesn’t Last Yael L. Maxwell October 13, 2025
News Conference News ESC 2025 DAPT’s Role After CABG Questioned: TACSI and TOP-CABG Caitlin E. Cox September 05, 2025
News Conference News NY Valves 2025 Solid, Early Surgical Results With Polymer Mitral Valve Todd Neale July 02, 2025
News Daily News Lower Mortality for AF Patients When Surgical Ablation Added to CABG: Medicare Yael L. Maxwell June 20, 2025
News Conference News ACC 2025 EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes L.A. McKeown April 07, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Daily News REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF Michael O'Riordan March 11, 2025
News Conference News STS 2025 Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis Yael L. Maxwell February 05, 2025
News Daily News Potential Sex Differences Seen for FFR-Guided PCI vs CABG in FAME 3 Todd Neale December 09, 2024
Presentation AHA 2024 Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement Presenter: Chisato Izumi November 17, 2024